Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 960

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 8
Chunk 960
---
237,880  
    $173,198,066  
     188,966,002 

Geographic information:

RENB,
BioSymetrics and RENC are managed on a worldwide basis but operate in offices located in the United States and the Netherlands, respectively.
The geographic information analyses the Company’s operations and assets based on the country in which each segment operates. In
presenting this geographic information, segment operating results have been based on the geographic location in which the services were
provided to the segment and segment assets were based on the geographic location of the assets.

    F-35

NOTE 15 — SUBSEQUENT EVENTS

On
September 18, 2025, the Company filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the “Certificate
of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-10
reverse stock split of the shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”),
either issued and outstanding or held by the Company as treasury stock, effective as of 12:01 a.m. (New York time) on September 29, 2025
(the “Reverse Stock Split”). The Common Stock will begin trading on a
reverse stock split-adjusted basis on The Nasdaq Capital Market on September 30, 2025.

On September 18, 2025, the Company entered into the
First Amendment to Convertible Promissory Note whereby the January 2024 Note (see Note 8 to the Financial Statements) that matured on
December 29, 2024, was amended extending the Maturity Date in the second paragraph of the Note from December 29, 2024 to December 29,
2025. Accordingly, the Note unless otherwise amended, replaced, or otherwise altered by this First Amendment, any and all terms contained
in the Note continue in full force and effect.

On September 2, 2025, the Court
of Amsterdam (the “Court”) declared bankrupt Gedi Cube B.V. (“Gedi”), an indirect subsidiary of Lunai Bioworks,
Inc. (“Lunai”), and appointed Mr. M.M. Dellebeke as the receiver in the bankruptcy. Gedi filed a voluntary petition seeking
a declaration of bankruptcy due to its inability to make payments as they became due. As a result of this, the Company determined that
a material impairment of Gedi